Tammy Duckworth sold Chemours Co (NYSE: CC)
Tammy Duckworth (D-IL), a U.S. Senator, has disclosed 1 trade in Chemours Co (CC) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Tammy Duckworth sold $1,001 - $15,000 of Chemours Co (NYSE: CC) on October 10, 2017. Since that trade, CC is down -58.70% against the S&P 500 up +227.17%, an outperformance of -285.87%.
Data updated
Tammy Duckworth's CC trades vs the price
CC is down -58.70% since Tammy Duckworth sold on October 10, 2017, versus +227.17% for the S&P 500.
Performance since this trade
All Tammy Duckworth CC trades
Tammy Duckworth & CC trading FAQ
Is it legal for Tammy Duckworth to trade Chemours Co (CC) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Chemours Co (CC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Tammy Duckworth sell CC?
Tammy Duckworth disclosed a sale of $1,001 - $15,000 of Chemours Co (CC) on October 10, 2017, according to public STOCK Act filings.
How has CC performed since Tammy Duckworth's trade?
Since Tammy Duckworth sold CC on October 10, 2017, the stock is down -58.70%, versus +227.17% for the S&P 500 over the same period, an outperformance of -285.87%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CC trades?
Quantellect tracks every disclosed congressional trade in Chemours Co (CC) on the Chemours Co congressional trading page, which aggregates filings across all members of Congress.
Tammy Duckworth's CC tradesAll congressional filings for Chemours CoTammy Duckworth's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.